Vectans Pharma

Vectans Pharma is a private, Paris-based biotech focused on developing optimized therapeutics through its Lauriad® platform technology. The company has commercialized products and is actively pursuing pipeline development in anti-infectives and supportive care, with a strategy centered on lifecycle management and OTC switching. Its international commercial footprint, collaborative R&D approach, and platform-driven optimization of existing molecules position it to address unmet needs in large markets.

Proprietary Lauriad® technology platform for optimizing existing treatments and developing novel therapeutics, focused on creating 'best-in-disease' products through formulation or delivery enhancements.

Vectans competes in the crowded space of anti-infectives and supportive care, facing competition from large pharmaceutical originators, generic companies, and other specialty pharma firms focused on drug delivery and formulation improvements. Its differentiation hinges on the perceived clinical and commercial advantages conferred by its Lauriad® platform.